Report Details

Global (United States, China, Japan, Europe, MEA, LATAM, RoW) Pet Vaccine  Market Size, Growth Drivers and Trend to 2028

Global (United States, China, Japan, Europe, MEA, LATAM, RoW) Pet Vaccine Market Size, Growth Drivers and Trend to 2028

Report Format PDF & Excel
Pages 117
Publish Date Apr, 2019

The global Pet Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pet Vaccine market based on company, product type, end user and key regions.


This report studies the global market size of Pet Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pet Vaccine in these regions.

This research report categorizes the global Pet Vaccine market by top players/brands, region, type and end user. This report also studies the global Pet Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.


The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Bayer Healthcare

Vetoquinol S.A

Boehringer Ingelheim

Ceva

Eli Lilly

Heska Co.

Merck Animal Health

Merial (Sanofi)

Virbac

Zoetis (Pfizer)


Market size by Product

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Market size by End User

Canine

Avian

Feline


Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa


The study objectives of this report are:

To study and analyze the global Pet Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Pet Vaccine market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Pet Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Pet Vaccine submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.


In this study, the years considered to estimate the market size of Pet Vaccine are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025


This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pet Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.


For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage

1.1 Pet Vaccine Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Pet Vaccine Market Size Growth Rate by Product

1.4.2 Attenuated Live Vaccines

1.4.3 Conjugate Vaccines

1.4.4 Inactivated Vaccines

1.4.5 Subunit Vaccines

1.4.6 Toxoid Vaccines

1.4.7 DNA Vaccines

1.4.8 Recombinant Vaccines

1.5 Market by End User

1.5.1 Global Pet Vaccine Market Size Growth Rate by End User

1.5.2 Canine

1.5.3 Avian

1.5.4 Feline

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Pet Vaccine Market Size

2.1.1 Global Pet Vaccine Revenue 2014-2025

2.1.2 Global Pet Vaccine Sales 2014-2025

2.2 Pet Vaccine Growth Rate by Regions

2.2.1 Global Pet Vaccine Sales by Regions

2.2.2 Global Pet Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Pet Vaccine Sales by Manufacturers

3.1.1 Pet Vaccine Sales by Manufacturers

3.1.2 Pet Vaccine Sales Market Share by Manufacturers

3.1.3 Global Pet Vaccine Market Concentration Ratio (CR5 and HHI)

3.2 Pet Vaccine Revenue by Manufacturers

3.2.1 Pet Vaccine Revenue by Manufacturers (2014-2019)

3.2.2 Pet Vaccine Revenue Share by Manufacturers (2014-2019)

3.3 Pet Vaccine Price by Manufacturers

3.4 Pet Vaccine Manufacturing Base Distribution, Product Types

3.4.1 Pet Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Pet Vaccine Product Type

3.4.3 Date of International Manufacturers Enter into Pet Vaccine Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Pet Vaccine Sales by Product

4.2 Global Pet Vaccine Revenue by Product

4.3 Pet Vaccine Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Pet Vaccine Breakdown Data by End User

6 North America

6.1 North America Pet Vaccine by Countries

6.1.1 North America Pet Vaccine Sales by Countries

6.1.2 North America Pet Vaccine Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Pet Vaccine by Product

6.3 North America Pet Vaccine by End User

7 Europe

7.1 Europe Pet Vaccine by Countries

7.1.1 Europe Pet Vaccine Sales by Countries

7.1.2 Europe Pet Vaccine Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Pet Vaccine by Product

7.3 Europe Pet Vaccine by End User

8 Asia Pacific

8.1 Asia Pacific Pet Vaccine by Countries

8.1.1 Asia Pacific Pet Vaccine Sales by Countries

8.1.2 Asia Pacific Pet Vaccine Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Pet Vaccine by Product

8.3 Asia Pacific Pet Vaccine by End User

9 Central & South America

9.1 Central & South America Pet Vaccine by Countries

9.1.1 Central & South America Pet Vaccine Sales by Countries

9.1.2 Central & South America Pet Vaccine Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Pet Vaccine by Product

9.3 Central & South America Pet Vaccine by End User

10 Middle East and Africa

10.1 Middle East and Africa Pet Vaccine by Countries

10.1.1 Middle East and Africa Pet Vaccine Sales by Countries

10.1.2 Middle East and Africa Pet Vaccine Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Pet Vaccine by Product

10.3 Middle East and Africa Pet Vaccine by End User

11 Company Profiles

11.1 Bayer Healthcare

11.1.1 Bayer Healthcare Company Details

11.1.2 Company Business Overview

11.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.1.4 Bayer Healthcare Pet Vaccine Products Offered

11.1.5 Bayer Healthcare Recent Development

11.2 Vetoquinol S.A

11.2.1 Vetoquinol S.A Company Details

11.2.2 Company Business Overview

11.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.2.4 Vetoquinol S.A Pet Vaccine Products Offered

11.2.5 Vetoquinol S.A Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Company Business Overview

11.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Boehringer Ingelheim Pet Vaccine Products Offered

11.3.5 Boehringer Ingelheim Recent Development

11.4 Ceva

11.4.1 Ceva Company Details

11.4.2 Company Business Overview

11.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Ceva Pet Vaccine Products Offered

11.4.5 Ceva Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Company Business Overview

11.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Eli Lilly Pet Vaccine Products Offered

11.5.5 Eli Lilly Recent Development

11.6 Heska Co.

11.6.1 Heska Co. Company Details

11.6.2 Company Business Overview

11.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Heska Co. Pet Vaccine Products Offered

11.6.5 Heska Co. Recent Development

11.7 Merck Animal Health

11.7.1 Merck Animal Health Company Details

11.7.2 Company Business Overview

11.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.7.4 Merck Animal Health Pet Vaccine Products Offered

11.7.5 Merck Animal Health Recent Development

11.8 Merial (Sanofi)

11.8.1 Merial (Sanofi) Company Details

11.8.2 Company Business Overview

11.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Merial (Sanofi) Pet Vaccine Products Offered

11.8.5 Merial (Sanofi) Recent Development

11.9 Virbac

11.9.1 Virbac Company Details

11.9.2 Company Business Overview

11.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.9.4 Virbac Pet Vaccine Products Offered

11.9.5 Virbac Recent Development

11.10 Zoetis (Pfizer)

11.10.1 Zoetis (Pfizer) Company Details

11.10.2 Company Business Overview

11.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered

11.10.5 Zoetis (Pfizer) Recent Development

12 Future Forecast

12.1 Pet Vaccine Market Forecast by Regions

12.1.1 Global Pet Vaccine Sales Forecast by Regions 2019-2025

12.1.2 Global Pet Vaccine Revenue Forecast by Regions 2019-2025

12.2 Pet Vaccine Market Forecast by Product

12.2.1 Global Pet Vaccine Sales Forecast by Product 2019-2025

12.2.2 Global Pet Vaccine Revenue Forecast by Product 2019-2025

12.3 Pet Vaccine Market Forecast by End User

12.4 North America Pet Vaccine Forecast

12.5 Europe Pet Vaccine Forecast

12.6 Asia Pacific Pet Vaccine Forecast

12.7 Central & South America Pet Vaccine Forecast

12.8 Middle East and Africa Pet Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Pet Vaccine Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Pet Vaccine Product Picture

Table Pet Vaccine Market Segments

Table Key Manufacturers Pet Vaccine Covered

Table Global Pet Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)

Figure Global Pet Vaccine Sales Market Share by Product 2014-2025

Figure Attenuated Live Vaccines Product Picture

Table Major Manufacturers of Attenuated Live Vaccines

Figure Conjugate Vaccines Product Picture

Table Major Manufacturers of Conjugate Vaccines

Figure Inactivated Vaccines Product Picture

Table Major Manufacturers of Inactivated Vaccines

Figure Subunit Vaccines Product Picture

Table Major Manufacturers of Subunit Vaccines

Figure Toxoid Vaccines Product Picture

Table Major Manufacturers of Toxoid Vaccines

Figure DNA Vaccines Product Picture

Table Major Manufacturers of DNA Vaccines

Figure Recombinant Vaccines Product Picture

Table Major Manufacturers of Recombinant Vaccines

Table Global Pet Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)

Figure Canine

Figure Avian

Figure Feline

Figure Pet Vaccine Report Years Considered

Figure Global Pet Vaccine Market Size 2014-2025 (Million US$)

Figure Global Pet Vaccine Sales 2014-2025 (K Doses)

Table Global Pet Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)

Table Global Pet Vaccine Sales by Regions 2014-2019 (K Doses)

Table Global Pet Vaccine Sales Market Share by Regions 2014-2019

Figure Global Pet Vaccine Sales Market Share by Regions 2014-2019

Figure 2018 Global Pet Vaccine Sales Market Share by Regions

Table Global Pet Vaccine Revenue by Regions 2014-2019 (Million US$)

Table Global Pet Vaccine Revenue Market Share by Regions 2014-2019

Figure Global Pet Vaccine Revenue Market Share by Regions 2014-2019

Figure 2018 Global Pet Vaccine Revenue Market Share by Regions

Table Global Pet Vaccine Sales by Manufacturers (2014-2019) (K Doses)

Table Global Pet Vaccine Sales Share by Manufacturers (2014-2019)

Figure Global Pet Vaccine Sales Share by Manufacturers in 2018

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Pet Vaccine Revenue by Manufacturers (2014-2019) (Million USD)

Table Pet Vaccine Revenue Share by Manufacturers (2014-2019)

Figure Pet Vaccine Value Share by Manufacturers in 2018

Table Key Manufacturers Pet Vaccine Price (2014-2019) (USD/Dose)

Table Pet Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Pet Vaccine Product Type

Table Date of International Manufacturers Enter into Pet Vaccine Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table Global Pet Vaccine Sales Share by Product (2014-2019)

Figure Global Pet Vaccine Sales Market Share by Product (2014-2019)

Figure Global Pet Vaccine Sales Market Share by Product in 2018

Table Global Pet Vaccine Revenue by Product (2014-2019) (Million US$)

Table Global Pet Vaccine Revenue Share by Product (2014-2019)

Figure Global Pet Vaccine Revenue Market Share by Product (2014-2019)

Figure Global Pet Vaccine Revenue Market Share by Product in 2018

Table Pet Vaccine Price by Product 2014-2019 (USD/Dose)

Table Global Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table Global Pet Vaccine Sales Share by End User (2014-2019)

Figure Global Sales Pet Vaccine Market Share by End User (2014-2019)

Figure Global Sales Pet Vaccine Market Share by End User in 2018

Figure North America Pet Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure North America Pet Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table North America Pet Vaccine Sales by Countries (2014-2019) (K Doses)

Table North America Pet Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 North America Pet Vaccine Sales Market Share by Countries

Table North America Pet Vaccine Revenue by Countries (2014-2019) (Million US$)

Table North America Pet Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 North America Pet Vaccine Revenue Market Share by Countries

Figure United States Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure United States Pet Vaccine Revenue Growth Rate (2014-2019) (K Doses)

Figure Canada Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Canada Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Mexico Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Mexico Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table North America Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table North America Pet Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 North America Pet Vaccine Market Share by Product

Table North America Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table North America Pet Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 North America Pet Vaccine Market Share by End User

Figure Europe Pet Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Europe Pet Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Europe Pet Vaccine Sales by Countries (2014-2019) (K Doses)

Table Europe Pet Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Europe Pet Vaccine Sales Market Share by Countries

Table Europe Pet Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Europe Pet Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Europe Pet Vaccine Revenue Market Share by Countries

Figure Germany Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Germany Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure France Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure France Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure UK Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure UK Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Italy Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Italy Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Russia Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Russia Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Europe Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table Europe Pet Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Europe Pet Vaccine Market Share by Product

Table Europe Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table Europe Pet Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Europe Pet Vaccine Market Share by End User

Figure Asia Pacific Pet Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Asia Pacific Pet Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Asia Pacific Pet Vaccine Sales by Countries (2014-2019) (K Doses)

Table Asia Pacific Pet Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Pet Vaccine Sales Market Share by Countries

Table Asia Pacific Pet Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Asia Pacific Pet Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Pet Vaccine Revenue Market Share by Countries

Figure China Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure China Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Japan Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Japan Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Korea Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Korea Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure India Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure India Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Australia Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Australia Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Indonesia Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Indonesia Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Malaysia Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Malaysia Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Philippines Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Philippines Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Thailand Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Thailand Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Vietnam Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Vietnam Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Singapore Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Singapore Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Asia Pacific Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table Asia Pacific Pet Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Asia Pacific Pet Vaccine Market Share by Product

Table Asia Pacific Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table Asia Pacific Pet Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Asia Pacific Pet Vaccine Market Share by End User

Figure Central & South America Pet Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Central & South America Pet Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Central & South America Pet Vaccine Sales by Countries (2014-2019) (K Doses)

Table Central & South America Pet Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Central & South America Pet Vaccine Sales Market Share by Countries

Table Central & South America Pet Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Central & South America Pet Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Central & South America Pet Vaccine Revenue Market Share by Countries

Figure Brazil Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Brazil Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Argentina Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Argentina Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Central & South America Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table Central & South America Pet Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Central & South America Pet Vaccine Market Share by Product

Table Central & South America Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table Central & South America Pet Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Central & South America Pet Vaccine Market Share by End User

Figure Middle East and Africa Pet Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Middle East and Africa Pet Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Middle East and Africa Pet Vaccine Sales by Countries (2014-2019) (K Doses)

Table Middle East and Africa Pet Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Middle East and Africa Pet Vaccine Sales Market Share by Countries

Table Middle East and Africa Pet Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Middle East and Africa Pet Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Middle East and Africa Pet Vaccine Revenue Market Share by Countries

Figure GCC Countries Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure GCC Countries Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Turkey Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Turkey Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Egypt Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Egypt Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure South Africa Pet Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure South Africa Pet Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Middle East and Africa Pet Vaccine Sales by Product (2014-2019) (K Doses)

Table Middle East and Africa Pet Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Middle East and Africa Pet Vaccine Market Share by Product

Table Middle East and Africa Pet Vaccine Sales by End User (2014-2019) (K Doses)

Table Middle East and Africa Pet Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Middle East and Africa Pet Vaccine Market Share by End User

Table Bayer Healthcare Company Details

Table Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Bayer Healthcare Recent Development

Table Vetoquinol S.A Company Details

Table Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Vetoquinol S.A Recent Development

Table Boehringer Ingelheim Company Details

Table Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Boehringer Ingelheim Recent Development

Table Ceva Company Details

Table Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Ceva Recent Development

Table Eli Lilly Company Details

Table Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Eli Lilly Recent Development

Table Heska Co. Company Details

Table Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Heska Co. Recent Development

Table Merck Animal Health Company Details

Table Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Merck Animal Health Recent Development

Table Merial (Sanofi) Company Details

Table Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Merial (Sanofi) Recent Development

Table Virbac Company Details

Table Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Virbac Recent Development

Table Zoetis (Pfizer) Company Details

Table Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)

Table Zoetis (Pfizer) Recent Development

Table Global Pet Vaccine Sales Forecast by Regions 2019-2025 (K Doses)

Table Global Pet Vaccine Sales Market Share Forecast by Regions 2019-2025

Table Global Pet Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)

Table Global Pet Vaccine Revenue Market Share Forecast by Regions 2019-2025

Table Global Pet Vaccine Sales Forecast by Product 2019-2025 (K Doses)

Table Global Pet Vaccine Sales Market Share Forecast by Product 2019-2025

Table Global Pet Vaccine Revenue Forecast by Product 2019-2025 (Million US$)

Table Global Pet Vaccine Revenue Market Share Forecast by Product 2019-2025

Table Global Pet Vaccine Sales Forecast by End User 2019-2025 (K Doses)

Table Global Pet Vaccine Sales Market Share Forecast by End User 2019-2025

Figure North America Pet Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)

Figure North America Pet Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Europe Pet Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)

Figure Europe Pet Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Asia Pacific Pet Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)

Figure Asia Pacific Pet Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Central & South America Pet Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)

Figure Central & South America Pet Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Middle East and Africa Pet Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)

Figure Middle East and Africa Pet Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)

Table Pet Vaccine Value Chain

Table Pet Vaccine Customers List

Table Pet Vaccine Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Research Methodology
The research study released with title "Global (United States, China, Japan, Europe, MEA, LATAM, RoW) Pet Vaccine Market Size, Growth Drivers and Trend to 2028" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Key Executives Interviewed

Global Pet Vaccine Market analysis

Research Programs/Design
Historical Data (2017-2022E)
  • Industry Trends
  • Competition Analysis & Landscape
  • By Company
  • Product Launches
  • Joint Venture & Partnerships
  • Merger & Acquisitions
  • Market Segment
  • by Type
  • by Application / End Users
  • By Regions/ Geography
  • Value in Dollar Term
  • Segment Revenue for Major & Emerging Players
  • Market Share
  • % Growth Rate
  • Current Scenario Analysis
  • Sales Volume by Key Players
  • % Market Share & Position
  • % Growth Rate
Market Factor Analysis
  • Market Environment
  • Government Policy & Regulatory Factors
  • Technological Changes
  • Market Risks & Challenges
  • Market Drivers
  • Market Maturity Indicators
  • Impact of Cost Variance
  • Growth Determinants
Market Forecast (2023F-2028F)
  • Overall Size (Value & Volume*)
  • by Type
  • by Application
  • By Region / Country
  • Key Data (Value & Volume*)
  • %Market Share
  • %Growth Rate
  • CAGR (2023-2028)

Market Size Estimation

Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.

To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.

HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Global Pet Vaccine Market analysis. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Global Pet Vaccine Market analysis who then work towards appointment generation.

Primary Data Collection

The primary research is performed by taking the interviews of executives of various companies dealing in the Global Pet Vaccine Market analysis as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.

Secondary Sources

The secondary resources considered in the Global Pet Vaccine Market analysis study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.

Market Breakdown and Data Triangulation

To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Global (United States, China, Japan, Europe, MEA, LATAM, RoW) Pet Vaccine Market Size, Growth Drivers and Trend to 2028" .

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Research Journals
  • Company Websites
  • White Papers
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • HTF MI Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segment value
Qualitative Analysis
  • Influencing Trends
  • Market Potential
  • Market Risks and Opportunities
  • Growth Drivers and Constraints
  • Geographical Footprints
  • Government Policies
  • Company Websites and Press Releases
  • Survey Reports and Paid Databases
  • Annual Reports
  • Industry Associations
  • HTF MI Database

Key Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments
  • Market Forecast (Value & Volume*) by Application, Type & Region / Country
  • History and Forecast
  • Market Size (Value & Volume) by Application
  • Market Size by Regions, Status & Forecast
  • Market Share & Growth Rate by Type & Application
  • Value by Key Business Segments
  • % Growth Rate by Segments
  • Growth Rate and Market Share by Regions
  • Market Size Status & Forecast
Total Market
  • Overall Size, Status & Forecast
  • Market Size Status & Forecast
Format Properties
1-User Access The report is sent in PDF format. The report will be emailed to you. This is a single user access license, allowing one specific user to access the report.
Site User The study would be provided in PDF format. The report will be emailed to you. This is a site license, allowing 1-10 employees within your organisation to access the report.
Enterprise User The format of deliverable would be PDF and Excel. This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report.

Frequently Asked Questions (FAQ):

The market study guides ( Japan MEA LATAM RoW) Pet Vaccine companies with strategic planning to ensure they realize and drive business value from their plans for growth strategy.
The market opportunity is clear from the flow of investment into ( Japan MEA LATAM RoW) Pet Vaccine market, utilizing technologies to drive efficiency and high volume.
( Japan MEA LATAM RoW) Pet Vaccine market share surpassed USD xx million in 2020 and will expand at a CAGR of yy% between 2021 and 2027.
The ( Japan MEA LATAM RoW) Pet Vaccine market is projected to register a moderate CAGR during forecast period of 2024 to 2029
Companies of ( Japan MEA LATAM RoW) Pet Vaccine Industry are studied thoroughly and profiled so as to understand why specific trends will have a high impact and how they are factored into the ( Japan MEA LATAM RoW) Pet Vaccine market trajectory and future outlook.